Polyglutamine expansion causes neurodegeneration by altering the neuronal differentiation program

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Huntington's disease (HD) and spinocerebellar ataxia type 7 (SCA7) are inherited neurodegenerative diseases linked to polyglutamine (polyQ) protein expansion.
• Transcriptional dysregulation is a common feature, but its role in neurodegeneration is not fully understood.

Purpose of the Study:

• To investigate the molecular pathways of polyQ expansion toxicity in the retina using mouse models of HD and SCA7.
• To correlate gene expression changes with functional and morphological defects in photoreceptors.

Main Methods:

• Utilized R6/2 (HD) and R7E (SCA7) mouse models exhibiting comparable retinal degeneration.
• Employed gene expression profiling and molecular biology techniques.

Main Results:

• Both models showed significant loss of gene expression critical for phototransduction and rod photoreceptor differentiation.
• Key transcription factors (Nrl, Crx, Nr2e3) regulating rod development were down-regulated.
• Aberrant reactivation of Stat3, an inhibitor of photoreceptor differentiation, was observed.

Conclusions:

• PolyQ expansion independently disrupts neuronal differentiation and maintenance, irrespective of the specific protein context.
• This disruption leads to photoreceptor dysfunction and degeneration in HD and SCA7 models.
• The retina serves as a valuable model for studying polyQ-induced neurodegeneration.